Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06844643

The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,250 (estimated)
Sponsor
China-Japan Friendship Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

An observational, ambispective cohort to learn about the disease progression of axial spondyloarthritis (axSpA) according to the changes from baseline in measures of disease activity, function, and imaging.

Detailed description

This is an observational cohort study of Chinese patients (≥18 years of age) diagnosed with axSpA. Patients are followed at 4-6 month intervals. Data will be collected at baseline and at every follow-up time points. Primary outcomes are the structural damage measured with imaging(Conventional radiography, low-dose CT and MRI) and the disease activity measured with the Ankylosing Spondylitis Disease Activity Scale (ASDAS) and the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). Secondary outcomes are inflammatory markers, Bath ankylosing spondylitis functional index (BASFI) and Bath ankylosing spondylitis metrology index (BASMI).

Conditions

Timeline

Start date
2025-03-01
Primary completion
2030-12-01
Completion
2030-12-01
First posted
2025-02-25
Last updated
2026-04-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06844643. Inclusion in this directory is not an endorsement.